Results 131 to 140 of about 173,850 (199)

A Morphological Study of HLA-DR-Immunopositive Cells in Multiple Sclerosis Lesions and Their Implications for Pathogenesis. [PDF]

Diagnostics (Basel)
Alturkustani M, Ang LC.
europepmc   +1 more source

Aging Adipose-Derived Mesenchymal Stem Cells, Cultured on a Native Young Extracellular Matrix, Are Protected From Senescence and Apoptosis Along With Increased Expression of HLA-DR and CD74 Associated With PI3K Signaling. [PDF]

Aging Cell
Gonzalez AO, Abdul Azees PA, Chen JP, Marinkovic M, Cao B, Liang T, Hu P, Yeh CK, Dean DD, Bai Y, Chen XD.   +10 more
europepmc   +1 more source

Humanization of Pan-HLA-DR mAb 44H10 Hinges on Critical Residues in the Antibody Framework. [PDF]

Antibodies (Basel)
Kassardjian A, Ivanochko D, Barber B, Jetha A, Julien JP.   +4 more
europepmc   +1 more source

HLA-DR⁺ regulatory T cells and IL-10 are associated with success or failure of desensitization outcomes. [PDF]

Allergy
Zhou X, Dunham D, Sindher SB, Long A, Fernandes A, Chang I, Assa'ad A, Pongracic J, Spergel JM, Tam J, Tilles S, Wang J, Boyd SD, Chinthrajah RS, Nadeau KC.   +14 more
europepmc   +1 more source

Multimodal Approach in Dry Eye Disease Combining In Vivo Confocal Microscopy and HLA-DR Expression. [PDF]

Transl Vis Sci Technol
Blautain B, Rabut G, Dupas B, Riancho L, Liang H, Luzu J, Labbé A, Garrigue JS, Brignole-Baudouin F, Baudouin C, Kessal K.   +10 more
europepmc   +1 more source

Activated HLA-DR+CD38+ Effector Th1/17 Cells Distinguish Crohn's Disease-associated Perianal Fistulas from Cryptoglandular Fistulas. [PDF]

Inflamm Bowel Dis
Ouboter LF, Lindelauf C, Jiang Q, Schreurs M, Abdelaal TR, Luk SJ, Barnhoorn MC, Hueting WE, Han-Geurts IJ, Peeters KCMJ, Holman FA, Koning F, van der Meulen-de Jong AE, Pascutti MF.   +13 more
europepmc   +1 more source

The mediating role of the genetically predicted N6, N6, N6-trimethyllysine levels in the association between HLA DR on CD14- CD16+ monocytes and ankylosing spondylitis. [PDF]

Medicine (Baltimore)
Hua D, Wang L, Li N, Xu X, Yin X.
europepmc   +1 more source

HLA-DR-Expressing Fibroblast-Like Synoviocytes Are Inducible Antigen Presenting Cells That Present Autoantigens in Lyme Arthritis. [PDF]

ACR Open Rheumatol
Rouse JR, Danner R, Wahhab A, Pereckas M, Nguyen C, McClune ME, Steere AC, Strle K, Jutras BL, Lochhead RB.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

HLA-DR is a procoagulant

Biochemical and Biophysical Research Communications, 1991
Numerous incidents of thromboembolic complications have been documented in cancer patients and in recipients of mismatched organ transplants. Tumor procoagulants have also been implicated in the process of metastasis. Two protein bands of 35,000 and 28,000 daltons isolated from human ovarian carcinoma possessed procoagulant activity.
M, Chelladurai, K V, Honn, D A, Walz
openaire   +2 more sources

Targeting HLA-DR

Leukemia & Lymphoma, 2009
The MHC class II human leukocyte antigens (HLAs) are 60-kDa transmembrane αβ heterodimers expressed on the cell surface of antigen presenting cells.
Kevin, Tay, Kieron, Dunleavy, Wyndham H, Wilson   +2 more
openaire   +2 more sources